Skip to main content
. 2007 Nov 14;46(1):198–205. doi: 10.1128/JCM.01459-07

TABLE 3.

Comparison of patients with and those without A. baumannii clone Aa

Patient characteristic Value for patients:
P value
With clone A (n = 44) Without clone A (n = 43)
Mean age (yr) (SD) 43.0 (14.9) 48.9 (16.6) 0.087
No. of men (%) 30 (68.2) 31 (72.1) 0.691
Race [no. (%)]
    African-American 18 (40.9) 18 (41.9) 0.971
    White, non-Hispanic 11 (25.0) 9 (20.9)
    Hispanic, any race 12 (27.3) 13 (30.2)
    Asian 3 (6.8) 3 (7.0)
Hospital acquired [no. (%)] 39 (90.7) 44 (100) 0.052
In ICU when organism was isolated [no. (%)] 35 (81.4) 40 (90.9) 0.198
ICU specialty [no. (%)] 0.137
    Surgical 25 (56.8) 28 (56.0)
    Medical 13 (29.5) 5 (11.6)
    Neurosurgical 6 (13.6) 3 (7.0)
Mean time from ICU admission to isolate isolation (days) (SD) 17.8 (9.9) 14.7 (10.4) 0.114
Mechanically ventilated at time of initial organism isolation [no. (%)] 33 (62.8) 27 (75.0) 0.210
Central bloodstream catheter present at time of initial organism isolation [no. (%)] 35 (81.4) 32 (72.7) 0.337
Surgical procedure prior to organism isolation [no. (%)] 38 (86.4) 34 (79.1) 0.361
Received expanded-spectrum cephalosporin 30 days prior to initial organism isolation [no. (%)] 39 (88.6) 31 (72.1) 0.051
Mean modified APACHE II score (SD) 13.3 (7.0) 13.9 (9.1) 0.780
Bloodstream infection [no. (%)] 37 (84.1) 7 (15.9) <0.001
Died during hospitalization [no. (%)] 20 (45.5) 8 (18.6) 0.007
a

Characteristics of infected versus colonized patients were compared with a Student's t test or Wilcoxon rank sum test for continuous variables and with χ2 tests for categorical variables.